CLINICAL TRIALS PROFILE FOR CLARITIN REDITABS
✉ Email this page to a colleague
All Clinical Trials for CLARITIN REDITABS
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00762983 ↗ | Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) | Completed | Merck Sharp & Dohme Corp. | 2008-03-01 | The purpose of this study is to collect information on unexpected adverse reactions (ADRs), how often ADRs occur, and factors that can affect the safety and effectiveness of Claritin (loratadine) when used in children. Patients will be observed while they are taking Claritin, and ADRs and symptom scores will be recorded. At the end of treatment, improvement in symptoms will be recorded. Post-marketing surveys are not considered applicable clinical trials and thus the results of this survey will not be posted at its conclusion. The results will be submitted to public health officials as required by applicable national and international laws. | |
NCT00776217 ↗ | Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions | Completed | Ranbaxy Laboratories Limited | N/A | 2006-06-01 | To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories (a subsidiary of Ranbaxy Pharmaceuticals Inc., USA) with Claritin® Reditabs® (containing loratadine 10 mg) of Schering-Plough Healthcare Product Inc., USA in healthy, adult, human male subjects under fasting condition. |
NCT00776282 ↗ | Bioequivalence Study of Loratadine Orally Disintegrating Tablets 10 mg Under Fed Conditions | Completed | Ranbaxy Laboratories Limited | N/A | 2006-07-01 | To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories Inc (A subsidiary of Ranbaxy Pharmaceuticals, Inc. USA) with Claritin® Reditabs® (containing loratadine 10 mg) of Schering-Plough Healthcare Product Inc., USA in healthy, adult, human male subjects under fed condition. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CLARITIN REDITABS
Condition Name
Clinical Trial Progress for CLARITIN REDITABS
Clinical Trial Phase
Clinical Trial Sponsors for CLARITIN REDITABS
Sponsor Name